Urinary Incontinence
Conditions
Interventions
Clinical trial, randomized and double-blind. The population will consist of menopausal women diagnosed with sexual and urinary dysfunction, living in the city of Natal/RN. The study will take place at
classification of urinary loss (using the International Consultation on Incontinence Questionnaire - Short Form - ICIQ-SF)
assessment of quality of life (using the Utian Quality of Life Scale - UQOL)
evaluation of the intervention (using the Patient Global Impression of Improvement - PGI-I)
regarding the functionality of the pelvic floor muscles: muscle strength (through the Modified Oxford Scale)
muscle pressure (through vaginal manometry)
Vaginal Health Index (through the Vaginal Health Index - VHI) and vaginal pH. PFMTG treatment will consist of four exercise modalities: (a) warm-up, (b) breathing exercises, (c) abdominal exercises an
Sponsors
Universidade Federal do Rio Grande do Norte
Universidade Federal do Rio Grande do Norte
Eligibility
Sex/Gender
Female
Age
45 Years to 65 Years
Inclusion criteria
Inclusion criteria: Women who had natural menopause at least 1 year ago; aged between 45-65 years; without use of hormone replacement therapy for at least 3 months; being sexually active; presenting a diagnosis of sexual dysfunction and urinary incontinence; not performing exercises for the pelvic floor muscles; have a negative Pap smear result for cervical cancer precursor cells in the last year
Exclusion criteria
Exclusion criteria: Women who present null value in the International Consultation on Incontinence Questionnaire - Short Form (ICIQ-SF); score above 26.55 in the Female Sexual Function Index (FSFI); those unable to understand simple verbal commands or who do not comply with the guidelines provided during the evaluation; volunteers with infectious and degenerative diseases; those who present genital prolapse III or IV according to the Baden-Walker Scale; report of unbearable pain during the gynecological evaluation; have more than 20% absences in the period of intervention; those who decide not to continue in the research and/or withdraw their consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the manometry of the pelvic floor musculature in menopausal women diagnosed with sexual and urinary dysfunction. | — |
Secondary
| Measure | Time frame |
|---|---|
| Evaluate the effect of photobiomodulation therapy on vaginal pH; to evaluate the quality of life before and after the training programs in both groups; assess the level of adherence to treatments; evaluate the improvement of the clinical condition through the Global Perception of Change Scale after the intervention and one month after application. | — |
Countries
Brazil
Contacts
Public ContactLívia Bezerra
Universidade Federal do Rio Grande do Norte
Outcome results
None listed